lunes, 19 de octubre de 2026

PHESGO: Proven efficacy and a convenient method of administration Subcutaneous administration in minutes, without compromising on efficacy

HER2-targeted therapies have transformed the HER2+ breast cancer landscape Give your patients a proven treatment approach that balances efficacy with well-established safety profiles, keeping your patients' quality of life at the centre of your treatment approach. https://global.phesgo-hcp.com/?cid=na7759503509&utm_source=medscape&utm_medium=na&utm_campaign=her2_2026&utm_content=tx%3Aphesgonc5%3A2609%3Axx&dclid=CjkKEQjw_9bWBhDiscOaku6CnKkBEiQAKCg80ktc7Kj_Slf6KPtBQnPnT8UVfo34wD9aElkpGuCBeofw_wcB&gad_source=7

No hay comentarios:

Publicar un comentario